The three‑month return of +24.6% versus the S&P's +15.0% is the most compelling recent metric, as it demonstrates that CNNE can generate alpha during bullish phases, which may support a case for allocating to the stock in momentum‑driven strategies.
The sustained negative annualized returns—especially a -23.9% one‑year loss versus the S&P's -47.5%—highlight ongoing profitability challenges; if earnings do not improve, the stock may continue to underperform absolute benchmarks despite its relative edge, posing a risk of capital erosion for long‑term holders.
While institutions are net buyers, the concentration of ownership near 79% creates liquidity risk; any coordinated sell‑off could compress the share supply quickly and exacerbate price declines, potentially magnifying the already high max drawdown of -51.1%.
The persistent -13.8% three‑year revenue CAGR is the most concerning growth signal, as it signals that the firm has been unable to reverse its downward trajectory over multiple cycles, weakening any upside narrative for investors.
The net margin of -121.2% quantifies an alarming loss depth— for every $1 of sales the company loses $1.21, a level that can quickly deplete cash reserves and force equity dilution or debt financing under unfavorable terms.
The net profit margin’s plunge to -121.2% is the dominant driver of the ROE collapse, implying that for every $1 of revenue the company incurs $1.21 in losses—a red flag that profitability is not merely thin but deeply negative.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -50.1 | -121.2 | 0.32 | 1.29 | -32.2 | -10.0 | -38.9 |
| 2024 | -16.6 | -67.3 | 0.20 | 1.21 | -32.7 | -5.0 | -13.7 |
| 2023 | -13.5 | -55.0 | 0.21 | 1.16 | -34.7 | -4.6 | -11.7 |
| 2022 | -15.7 | -64.7 | 0.21 | 1.15 | -28.4 | -4.8 | -13.7 |
| 2021 | -8.6 | -38.7 | 0.19 | 1.17 | -45.3 | -3.6 | -7.4 |
| 2020 | 47.3 | 305.0 | 0.13 | 1.22 | -17.2 | -4.3 | 38.7 |
| 2019 | 3.1 | 4.4 | 0.51 | 1.41 | -11.7 | -5.7 | 2.2 |
| 2018 | 2.5 | 2.3 | 0.83 | 1.30 | -18.4 | -11.5 | 1.9 |
| 2017 | 10.3 | 9.3 | 0.79 | 1.40 | -10.6 | -6.3 | 7.3 |
| 2016 | -1.4 | -1.1 | 0.80 | 1.65 | -0.4 | -0.2 | -0.8 |
| 2015 | -2.4 | -1.6 | 0.96 | 1.56 | -1.5 | -0.9 | -1.6 |
The -32.2% ROIC translates to an annual erosion of roughly $32 million for every $100 million of invested capital, which could force asset write‑downs or aggressive financing to sustain operations if the trend persists.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1138 | 0 | 52 | 143 | 91 | -38 |
| 2024 | 1798 | 0 | 29 | 160 | 13 | 15 |
| 2023 | 1720 | 0 | 17 | 129 | 19 | -2 |
| 2022 | 1723 | 0 | 1 | 134 | 15 | -14 |
| 2021 | 1913 | 0 | 0 | 134 | 12 | -12 |
| 2020 | 2875 | 0 | 11 | 217 | 15 | -4 |
| 2019 | 714 | 6 | 5 | 121 | 7 | 4 |
| 2018 | 442 | 7 | 9 | 53 | 7 | 9 |
| 2017 | 464 | 10 | 11 | 68 | 7 | 14 |
| 2016 | 456 | 8 | 8 | 73 | 9 | 7 |
| 2015 | 380 | 7 | 9 | 59 | 36 | -20 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1321M | $330M | $1024M | $332M | $150M | $182M | $268M | $130M |
| 2024 | $2229M | $414M | $1836M | $330M | $199M | $132M | $197M | $146M |
| 2023 | $2687M | $378M | $2324M | $274M | $168M | $106M | $177M | $108M |
| 2022 | $3126M | $411M | $2719M | $300M | $52M | $248M | $311M | $123M |
| 2021 | $3890M | $548M | $3335M | $236M | $150M | $86M | $122M | $180M |
| 2020 | $4613M | $828M | $3780M | $285M | $-439M | $725M | $844M | $202M |
| 2019 | $2092M | $562M | $1488M | $368M | $-165M | $534M | $631M | $199M |
| 2018 | $1460M | $260M | $1125M | $48M | $-275M | $323M | $456M | $160M |
| 2017 | $1487M | $334M | $1059M | $135M | $-111M | $246M | $350M | $250M |
| 2016 | $1473M | $464M | $894M | $135M | $-7M | $142M | $273M | $160M |
| 2015 | $1472M | $413M | $946M | $200M | $-75M | $275M | $387M | $160M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $-18M | $518M | $-450M | $-10M | $-28M | $-320M | $-30M |
| 2024 | $-90M | $298M | $-183M | $-7M | $-97M | $-235M | $-22M |
| 2023 | $-88M | $53M | $-107M | $-10M | $-98M | $-113M | |
| 2022 | $-205M | $521M | $-154M | $-14M | $-219M | $-230M | |
| 2021 | $-176M | $-272M | $-190M | $-14M | $-190M | $-160M | |
| 2020 | $-114M | $-74M | $379M | $-22M | $-136M | $-15M | |
| 2019 | $-84M | $-24M | $319M | $-28M | $-112M | $-6M | |
| 2018 | $-23M | $187M | $-86M | $-16M | $-39M | $-0M | |
| 2017 | $-91M | $92M | $98M | $-40M | $-131M | $-46M | |
| 2016 | $60M | $-168M | $-21M | $-55M | $5M | $-52M | |
| 2015 | $11M | $273M | $-212M | $-60M | $-49M | $-286M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net